Today: 1 May 2026
Salesforce stock price drops again as CRM enters March; what investors watch before Monday
1 March 2026
1 min read

Salesforce stock price drops again as CRM enters March; what investors watch before Monday

NEW YORK, March 1, 2026, 12:38 EST — Market closed.

Salesforce closed out Friday at $194.79, slipping 2.35% as the stock wrapped up a turbulent week for the enterprise software giant, just ahead of Monday’s U.S. session.

The reason this matters right now is clear. Every day, the question of whether generative AI will boost sales for major software vendors, or disrupt their traditional seat-based pricing, is getting priced in again. Salesforce stands out as a key bellwether in that ongoing debate.

The company’s push around “AI agents”—software designed to act on users’ behalf—has been flagged as the next growth driver. What traders want now: fewer pilots, more paid deployments that actually gain traction.

Salesforce wasn’t the only name sliding Friday. Oracle dropped 3.27%, while ServiceNow eased 1.18% during the session—a sign investors continue to lump enterprise software stocks together.

Salesforce disclosed in a Feb. 25 filing that it pulled in $11.2 billion in fourth-quarter revenue. The company’s RPO—contracted revenue still to be recognized—climbed 14% to reach $72.4 billion. Alongside those results, Salesforce unveiled a fresh $50 billion share buyback plan and bumped its quarterly dividend up to $0.44 per share. CEO Marc Benioff described the company as having been “rebuilt … to become the operating system for the Agentic Enterprise.” SEC

Rebecca Wettemann, CEO at Valoir, told Reuters this week that “Salesforce needs to show it is continuing to translate early AI traction into broader enterprise adoption.” Reuters

Friday was no relief. Reuters summed it up as a “risk-off” day, with software shedding 1.5% amid investor worries over AI shakeups, tariffs, and geopolitical tensions. Carson Group’s Ryan Detrick called the mood “a classic risk-off environment.” Reuters

CRM holders face a test Monday: are the sellers done, and will buyers step in? Keep an eye on how shares move compared to other software names. The pace at which traders latch onto—or dismiss—the newest AI angle will be telling.

But there’s risk on the other side too. Should enterprise spending remain constrained—and if AI agents wind up lowering per-user demand or nudging clients toward more budget options—the stock could keep slipping, buybacks or not.

Looking past individual companies, tech multiples face a packed macro calendar this week. Reuters’ Week Ahead flagged Friday, March 6, for the U.S. jobs report—a data point with the potential to jolt rate forecasts and, consequently, valuations for high-growth stocks.

Salesforce’s next notable event lands quickly: CFO Robin Washington and Joe Inzerillo are set to appear at the Morgan Stanley Technology, Media & Telecom Conference on March 3 at 2:35 p.m. PT. Investors are hoping the pair will deliver updated insight on demand trends and AI agent uptake.

Stock Market Today

  • Investors Eye FTSE 250's Applied Nutrition as Diageo Shares Falter
    May 1, 2026, 11:39 AM EDT. Diageo shares have slumped about 30% over the past year and more than 50% in five years, pressuring investors. Applied Nutrition, a FTSE 250 nutritional supplement supplier, offers a contrasting growth story with a 57% rise in sales over six months and a near 90% rise in share price over one year. The company benefits from booming health and wellness trends, expects 8% market growth annually through 2028, and features strong financials including a £25.4 million net cash position, 49% return on capital, and a modest forward price-to-earnings ratio of 17.5. Its business-to-business model with retailers like Tesco and Amazon helps navigate industry competition. Investors seeking to recover losses from Diageo may consider Applied Nutrition's robust outlook and expanding market.

Latest article

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

1 May 2026
Tempus AI will report first-quarter results on May 5 and hold its first investor day on May 29. Merck’s CEO highlighted Tempus in remarks on the drugmaker’s AI efforts in precision oncology. Tempus shares traded near $55.44 Friday, with a market value of about $9.7 billion. The company reported 2025 revenue of $1.27 billion and forecast $1.59 billion for 2026.
Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

1 May 2026
Rothschild & Co Redburn initiated Ciena with a Neutral rating and a $416 target, about 22% below Friday’s $534.43 share price, citing that much of the optical-networking upside is already priced in. Ciena reported Q1 revenue of $1.43 billion, up 33%, and raised its 2026 forecast. The company will showcase new optical products at ABRINT 2026 in São Paulo next week.
Amazon stock in focus after $50 billion OpenAI partnership lands in SEC filing
Previous Story

Amazon stock in focus after $50 billion OpenAI partnership lands in SEC filing

GE Aerospace stock price near record high as supply-chain bottlenecks stay in focus
Next Story

GE Aerospace stock price near record high as supply-chain bottlenecks stay in focus

Go toTop